88 related articles for article (PubMed ID: 29524839)
1. The effect of in silico targeting Pseudomonas aeruginosa patatin-like protein D, for immunogenic administration.
Chirani AS; Majidzadeh R; Pouriran R; Heidary M; Nasiri MJ; Gholami M; Goudarzi M; Omrani VF
Comput Biol Chem; 2018 Jun; 74():12-19. PubMed ID: 29524839
[TBL] [Abstract][Full Text] [Related]
2. Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization.
Ahmadbeigi Y; Chirani AS; Soleimani N; Mahdavi M; Goudarzi M
Mol Immunol; 2020 Aug; 124():70-82. PubMed ID: 32540517
[TBL] [Abstract][Full Text] [Related]
3. The Pseudomonas aeruginosa patatin-like protein PlpD is the archetype of a novel Type V secretion system.
Salacha R; Kovacić F; Brochier-Armanet C; Wilhelm S; Tommassen J; Filloux A; Voulhoux R; Bleves S
Environ Microbiol; 2010 Jun; 12(6):1498-512. PubMed ID: 20192961
[TBL] [Abstract][Full Text] [Related]
4. Immunoinformatics design of multivalent chimeric vaccine for modulation of the immune system in Pseudomonas aeruginosa infection.
Aminnezhad S; Abdi-Ali A; Ghazanfari T; Bandehpour M; Zarrabi M
Infect Genet Evol; 2020 Nov; 85():104462. PubMed ID: 32682863
[TBL] [Abstract][Full Text] [Related]
5. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.
Solanki V; Tiwari M; Tiwari V
Sci Rep; 2019 Mar; 9(1):5240. PubMed ID: 30918289
[TBL] [Abstract][Full Text] [Related]
6. A survey on chimeric UreB
Chirani AS; Ghazi M; Goudarzi M; Peerayeh SN; Soleimanjahi H; Dadashi M; Hajikhani B
Comput Biol Chem; 2018 Oct; 76():42-52. PubMed ID: 29929167
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of Lipid Targeting and Destruction by the Type V Secretion System of Pseudomonas aeruginosa.
da Mata Madeira PV; Zouhir S; Basso P; Neves D; Laubier A; Salacha R; Bleves S; Faudry E; Contreras-Martel C; Dessen A
J Mol Biol; 2016 May; 428(9 Pt A):1790-803. PubMed ID: 27012424
[TBL] [Abstract][Full Text] [Related]
8. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
Saadi M; Karkhah A; Nouri HR
Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
[TBL] [Abstract][Full Text] [Related]
9. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the immunopotentiation of P. aeruginosa PAPI-1 encoded pilin: From immunoinformatics survey to active immunization.
Jazi MA; Chirani AS; Hajikhani B; Ebrahimipour G; Goudarzi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111197. PubMed ID: 37951200
[TBL] [Abstract][Full Text] [Related]
11. An in silico structural and physicochemical characterization of TonB-dependent copper receptor in A. baumannii.
Abdollahi S; Rasooli I; Mousavi Gargari SL
Microb Pathog; 2018 May; 118():18-31. PubMed ID: 29524546
[TBL] [Abstract][Full Text] [Related]
12. Prediction of vaccine candidates against Pseudomonas aeruginosa: An integrated genomics and proteomics approach.
Rashid MI; Naz A; Ali A; Andleeb S
Genomics; 2017 Jul; 109(3-4):274-283. PubMed ID: 28487172
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
[TBL] [Abstract][Full Text] [Related]
14. Development of an epitope-based vaccine inhibiting immune cells rolling and migration against atherosclerosis using in silico approaches.
Tourani M; Karkhah A; Najafi A
Comput Biol Chem; 2017 Oct; 70():156-163. PubMed ID: 28886485
[TBL] [Abstract][Full Text] [Related]
15. Identification of epitopes in Leptospira borgpetersenii leucine-rich repeat proteins.
Nitipan S; Sritrakul T; Kunjantarachot A; Prapong S
Infect Genet Evol; 2013 Mar; 14():46-57. PubMed ID: 23201041
[TBL] [Abstract][Full Text] [Related]
16. Quest for Novel Preventive and Therapeutic Options Against Multidrug-Resistant
Irum S; Andleeb S; Ali A; Rashid MI; Majid M
Int J Pept Res Ther; 2021; 27(4):2313-2331. PubMed ID: 34393689
[TBL] [Abstract][Full Text] [Related]
17. A multi-subunit based, thermodynamically stable model vaccine using combined immunoinformatics and protein structure based approach.
Rana A; Akhter Y
Immunobiology; 2016 Apr; 221(4):544-57. PubMed ID: 26707618
[TBL] [Abstract][Full Text] [Related]
18. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; Garcia-Sastre A; Engelhardt OG; Palese P
Behring Inst Mitt; 1997 Feb; (98):291-301. PubMed ID: 9382753
[TBL] [Abstract][Full Text] [Related]
19. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach.
Meza B; Ascencio F; Sierra-Beltrán AP; Torres J; Angulo C
Infect Genet Evol; 2017 Apr; 49():309-317. PubMed ID: 28185986
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.
Robinson CM; Kobe BN; Schmitt DM; Phair B; Gilson T; Jung JY; Roberts L; Liao J; Camerlengo C; Chang B; Davis M; Figurski L; Sindeldecker D; Horzempa J
Bioengineered; 2015; 6(2):82-8. PubMed ID: 25617059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
